Researchers have begun to actively highlight the role of Nrf2 activation, mainly in transformed cells, in the progression of malignant neoplasms, contributing to tumor metastasis [185,186] and the acquisition of resistance to therapy [187] by maintaining reprogrammed cell metabolism under hypoxia [188]. Here, NFE2L2 is linked to neoplasm.